¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Calcium And Magnesium Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bilateral cleft lip and palate
    ¾çÂÊÀÔ¼úÀÔõÀå°¥¸²Áõ, ¾çÃø±¸¼ø±¸°³¿­
  • bread-and-butter pericarditis
    »§¹öÅ͸ð¾ç½ÉÀ帷¿°
  • complementary and alternative medicine
    º¸Ãæ´ë¾ÈÀÇÇÐ, º¸¿Ï´ëüÀÇÇÐ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • dilatation and curettage
    Àڱñܾ(¼ú), ÀÚ±Ã¼ÒÆÄ(¼ú)
  • foot-and-mouth disease
    ÀԹߺ´, ±¸Á¦¿ª
  • half and half nail
    ¹Ý°ú¹Ý¼Õ¹ßÅé
  • incision and drainage
    1. Àý°³¹è³ó(¼ú) 2. Àý°³¹è¾×(¼ú)
  • intake and output record
    ¼·Ãë¹è¼³·®±â·Ï
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • law of weights and measures
    °è·®¹ý
  • left and right handedness
    ¾ç¼ÕÀâÀÌ
  • maternal and child health
    ¸ðÀÚº¸°Ç
  • maternity and infant hygiene
    ¸ð¼º¿µ¾ÆÀ§»ý
  • picture archiving and communicating system
    ¿µ»óÀúÀå¹×Àü¼Ûü°è
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • oral infection
    ÀԾȰ¨¿°, °æ±¸°¨¿°
  • oral intake
    °æ±¸¼·Ãë
  • oral medication
    °æ±¸Åõ¾à
  • oral
    1.ÀÔ-, ±¸°­-, 2.°æ±¸-, 3.±¸¼ú-, ¸»-
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • oral ulcer
    ÀԱ˾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • exudative chronic discoid and lichenoid dermatitis
    »ïÃ⸸¼º¿ø¹Ýż±ÇǺο°
  • foot-and-mouth disease
    ÀԹ߱Áº´, ±¸Á¦¿ª
  • incision and drainage
    Àý°³¹è³ó
  • wear and tear dermatitis
    ¹Ýº¹ÀÚ±ØÇǺο°
  • embryonal and botryoid rhabdomyosarcoma
    ¹è¾ÆÆ÷µµÈ¾¹®±ÙÀ°Á¾
  • salt-and-pepper fundus
    ÈÄÃ߼ұݸð¾ç¾ÈÀú, ÈÄÃ߼ұݸð¾ç´«¹Ù´Ú
  • left and right handedness
    ¾ç¼ÕÀâÀÌ
  • maternal and child health
    ¸ðÀÚº¸°Ç
  • maternity and infant hygiene
    ¸ð¼º¿µ¾ÆÀ§»ý
  • intake and output record
    ¼·Ãë¹è¼³·®±â·Ï
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • law of weights and measures
    °è·®¹ý
  • trial-and-error learning
    ½ÃÇàÂø¿ÀÇнÀ
  • to and fro motion
    ¿Õº¹¿îµ¿
  • picture archiving and communicating system
    ¿µ»óÀúÀå¹×Àü¼Ûü°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Gravity, cardiac output and
    Áß·Â(ñìÕô), ½É¹ÚÃâ·®(ãýÚÑõóÕá)
  • KUB= kidney, ureter and bladder
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • PACS (picture archiving and communicating system)
    ÆÑ½º, ¿µ»ó ÀúÀå ¹× Àü¼Û ü°è
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • SADS, Schedule for Affective Disorders and Schizophrenia
    Á¤µ¿Àå¾Ö¿Í Á¤½ÅºÐ¿­º´ÀÇ Áø´ÜÀ» À§ÇÑ ¸ñ·Ï
  • SOFAS, Social and Occupational Functioning Assessment Scale
    »çȸ-Á÷¾÷±â´ÉÆò°¡Ã´µµ
  • SONAR(Sound Navigation and Ranging)
    ¼Ò³ª
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • alternate hot and cold caloric examination
    ³Ã¿Â±³´ë(¿Âµµ)Àڱذ˻ç(ÕÒè®Îßû»è®öôô§Ð½ËþÞÛ).
  • ambient temperature and pressure saturated with water vapor =ATP
    ½Ç¿Â´ë±â¾Ð ¼öÁõ±â Æ÷È­»óÅÂ
  • american society of therapeutic radiology and onco
    logy (ASTRO) ¹Ì±¹¹æ»ç¼±Á¾¾çÇÐȸ
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • glioma of optic nerve and chiasm
    ½Ã½Å°æ±³Â÷ ±³¼¼Æ÷Á¾.
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • magnesium sulfate
    Ȳ»ê(üÜß«)¸¶±×³×½·.
  • magnesium sulfate
    Ȳ»ê¸¶±×³×½·
  • magnesium trisilicate ³ª magnesii trisilicas
    »ï±Ô»ê(߲Щ߫)¸¶±×³×½·.
  • magnesium urate
    ¿ä»ê¸¶±×³×½·
  • calcium
    Ä®½·
  • calcium
    Ä®½·
  • calcium alterans
    Ä®½·±³´ë( -ÎßÓÛ).
  • calcium antagonist
    Ä®½·±æÇ×Á¦.
  • calcium balance
    Ä®½·ÆòÇü(¡­øÁû¬)
  • calcium bilirubinate crystal
    ºô¸®·çºó»êÄ®½·°áÁ¤
  • calcium carbonate
    ź»êÄ®½·
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
  • calcium channel antagonist,blocker
    Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • calcium chloride
    ¿°È­Ä®½·
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
  • Mesenteries and peritoneal folds
    âÀÚ°£¸· ¹× º¹¸·ÁÖ¸§
    [¿¾ ¿ë¾î] Àå°£¸·
  • Coeloms and septa
    ü°­°ú Áß°Ý
    [¿¾ ¿ë¾î] ü°­°ú Áß°Ý
  • Gray matter (Nuclei and Columns)
    ȸ»öÁú(½Å°æÇÙ°ú ½Å°æ±âµÕ)
    [¿¾ ¿ë¾î] ȸ¹éÁú
  • Cartilages and Articulations of Larynx
    Èĵο¬°ñ ¹× ÈĵΰüÀý
    [¿¾ ¿ë¾î] Èĵο¬°ñ ¹× ÈĵΰüÀý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
  • Lavoisier and Laplace law
    ¶óº¸¾ÆÁ¦ ¶óÇÁ¶óÀ̽º¹ýÄ¢(ÛööÎ)
  • lock and key theory
    ÀÚ¹°¼è-¿­¼èÀÌ·Ð(ìµÖå)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • "Monod, Wyman, and Changeux model"
    ¸ð³ë.¿ÍÀ̸¸.¼§Á¶¸ðµ¨
  • Park and Johnson method
    ÆÄÅ© Á¸½¼ ¹ý(Ûö)
  • patch and cut repair
    Àý´Ü ºÎ ¼öº¹(ï·Ó¨Ý¾áóÜÖ)
  • stem-and-loop DNA
    ÁÙ±â- ·çÇÁ DNA
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • PACS [=picture archiving and communicating system]
    ÆÑ½º, ¿µ»óÀúÀå ¹× Àü¼Ûü°è
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • R & F [=radiography and fluoroscopy]
    ¹æ»ç¼±ÃÔ¿µ ¹× Åõ½Ã±â
  • salt and pepper appearance
    ¼Ò±ÝÈÄÃß°¡·ç¸ð¾ç
  • SONAR [=Sound Navigation and Ranging]
    ¼Ò³ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OCP octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil...
OET oral endotracheal tube; oral esophageal tube
OHI Occupational Health Institute; operative hypertension indicator; oral hygiene index; Oral Hygiene In...
Mag magnesium
mag cit magnesium citrate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MgO Magnesium oxide
MgSO4 Magnesium sulphate
TMg Total magnesium
CMT choline magnesium trisalicylate
IMg(2+) ionized magnesium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium gluconate
    ±Û·çÄÜ »ê Ä®½·
    ±Û·çÄÜ »êÀÇ Ä®½·¿°. ¹«Ãë ¹«¹ÌÀÇ ¹é»ö °áÁ¤¼º °ú¸³ ¶Ç´Â ºÐ¸». Ä®½· º¸±Þ¿¡ Á¤Á¦ ¶Ç´Â ¾×ÀÌ »ç¿ëµÈ´Ù. ºÒÈ­¹°À̳ª ¼ö»ê Áßµ¶¿¡ ´ëÇÑ °æ±¸ ÇØµ¶Á¦ÀÌ´Ù.
  • calcium gout
    Ä®½· Åëdz
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium hypophosphate
    Ä®½· ¾ÆÀÎ»ê ¿°
    ÆÇÅäÅÙ »êÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ Ä®½· ¿°, B º¹ÇÕü ºñŸ¹Î. ¹é»öÀÇ ºÐ¸». ´Ù¸¥ ºñŸ¹Î B¿Í °áÇÕÇÏ¿© ¿µ¾ç °ø±Þ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • calcium levulinate
    ·¹ºÒ¸° »ê Ä®½·
    Ä®½· º¸½ÀÁ¦. ¹é»ö °áÁ¤¼º ¶Ç´Â ¹«Á¤Çü ºÐ¸¸. Ä®½· °áÇÌÁõÀÇ Ä¡·á¿¡ Ä®½· º¸±ÞÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium metabolism
    Ä®½·´ë»ç
    Ç÷ÀåÁßÀÇ Ä®½· ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ¸ç »ÀÀÇ ¼®È¸È­¸¦ À§ÇÑ Ä®½· °ø±ÞÀ» ÇÏ´Â »ýÈ­ÇÐÀû, »ý¸®ÇÐÀû °úÁ¤.
  • calcium oxide
    »êÈ­ Ä®½·
    ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êȭź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
  • calcium phosphate
    Àλê Ä®½·
    Ä®½·±â¿Í ÀÎ»ê ±â¸¦ °¡Áø ¿°À¸·Î ¼¼ °¡Áö ÇüŰ¡ ÀÖ´Ù.
  • calcium propionate
    ÇÁ·ÎÇǿ »ê Ä®½·
    ÇÁ·ÎÇǿ »êÀÇ Ä®½·¿°. Ç× Áø±Õ¼ºÀ» °®´Â´Ù. ´Üµ¶À¸·Î ¶Ç´Â ÇÁ·ÎÇǿ »ê ³ªÆ®·ýÀ̳ª ´Ù¸¥ ¿ä¼Ò¿Í °áÇÕÇÏ¿© ¹æºÎÁ¦¿Í ±¹¼ÒÀû Ç× Áø±ÕÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium pyrophosphate dihydrate
    À̼öÈ­ ÇÇ·ÎÀλê Ä®½·
  • calcium salt
    Ä®½· ¿°
  • calcium sulfate
    Ȳ»ê Ä®½·
    õ¿¬ÀûÀ¸·Î¼­ ¼®°í CaSO4, 2H2O ¹× °æ¼®°í CaSO4·Î½á »êÃâ, ÀüÀÚ¸¦ Å¿ö¼­ CaSO4, 1/2H2OÀÇ ¼Ò¼®°í·Î¼­ »ç¿ëÇÑ´Ù. À̰Ϳ¡ ¹°À» °¡ÇÏ¿© Àλóü³»¿¡ ÁÖÀÔ½ÃŰ¸é ¼öºÐ¿¡¼­ 10ºÐ »çÀÌ¿¡ ¼®°í°¡ µÇ°í °æÈ­µÈ´Ù. ¼®°íÀÇ ¿ëÇØµµ´Â 42¡É·Î¼­ ÃÖ°íÀÌ´Ù. ¼®°í ¸ðÇü Á¦ÀÛ µî¿¡ »ç¿ëµÈ´Ù.
  • calcium sulfate bonded investment
    ¼®°í°è ¸Å¸ôÀç, ¼®°í °áÇÕ ¸Å¸ôÀç
  • calcium sulfate hemihydrate
    ¹Ý¼ö ¼®°í
    À̼ö ¼®°í¸¦ °¥¾Æ¼­ 230¡­248¢µÀÇ ¿Âµµ¸¦ °¡ÇÏ¸é °áÁ¤Ã¼ ÁßÀÇ ÀϺΰ¡ »ÀÀÚ ³ª°¡ Ä¡°ú¿ë °æ¼®°í°¡ µÈ´Ù. È­ÇÐ ±¸Á¶½Ä CaSO4, 1/2H2O.
  • calcium-channel blocker
    Ä®½· Â÷´ÜÁ¦, Ä®½· Åë·Î Â÷´ÜÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
magnesium excess Persons with impaired kidney function should be especially careful about their magnesium intake because they can accumulate magnesium, a dangerous situation. According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
magnesium hydroxide <chemical> Magnesium hydroxide (mg(oh)2). An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.
Pharmacological action: antacids, cathartic.
Chemical name: Magnesium hydroxide (Mg(OH)2)
(12 Dec 1998)
magnesium lactate A laxative.
(05 Mar 2000)
magnesium oxide <chemical> Magnesium oxide (mgo). An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses.
Pharmacological action: antacids, cathartic.
Chemical name: Magnesium oxide (MgO)
(12 Dec 1998)
magnesium peroxide Decomposes in water to hydrogen peroxide; used as an ingredient in dentifrices and in antiseptic dusting powder.
(05 Mar 2000)
magnesium phytinates Chlorophyll a and b. See entries under chlorophyll.
(05 Mar 2000)
magnesium-protoporphyrin methyltransferase <enzyme> From photosynthetic tissue; catalyses the methylation of magnesium protoporphyrin in the presence of s-adenosyl-l-methionine to yield magnesium protoporphyrin monomethyl ester and s-adenosyl-l-homocysteine
Registry number: EC 2.1.1.11
Synonym: s-adenosyl-l-methionine-magnesium protoporphyrin methyltransferase, mg-pp-methyltransferase, s-adenosyl-l-methionine-mg-protoporphyrin ix methyltransferase, bchm gene product
(26 Jun 1999)
magnesium protoporphyrin monomethyl ester oxidative cyclase <enzyme> In chlorophyll biosynthesis converts -(ch2)2-coo-ch3 side chain of mg protoporphyrin monomethyl ester to -c=o-ch-cooch3 ring of mg 2,4-divinyl phaeoporphyrin a(5) monomethyl ester; requires NADPH and molecular oxygen; similar to cytochrome p-450 catalyzed systems but not inhibited by co
Registry number: EC 1.14.13.-
Synonym: mpme-oxidative cyclase
(26 Jun 1999)
magnesium salicylate A sodium-free salicylate derivative with anti-inflammatory, analgesic, and antipyretic actions; used for relief of mild to moderate pain.
(05 Mar 2000)
magnesium silicates A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include talc and some kinds of asbestos.
(12 Dec 1998)
magnesium stearate A compound of magnesium with variable proportions of stearic and palmitic acids; used in the preparation of tablets, as a lubricant, and as an ingredient in some baby powders.
(05 Mar 2000)
magnesium sulfate <chemical> Sulfuric acid magnesium salt (1:1). A small colourless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of preeclampsia and eclampsia. It causes direct inhibition of action potential in the myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions.
Pharmacological action: anticonvulsants, cathartic, tocolytic agents.
Chemical name: Sulfuric acid magnesium salt (1:1)
(12 Dec 1998)
magnesium trisilicate 2MgO-3SiO2-nH2O;a compound of magnesium oxide and silicon dioxide with varying proportions of water; occurs in nature as meerschaum, pararepiolite, and repiolite; a gastric antacid.
(05 Mar 2000)
potassium magnesium aspartate <chemical> An intra-extracellular electrolyte exchange agent with a variety of effects. Beneficial in cardiac insufficiency, potentiates the effect of cardiac glycosides by reducing their toxicity, has hypocholesteraemic effects and potentiates the effects of calcium in disturbed calcium metabolism.
Synonym: panangin; tromcardin.
Chemical name: DL-Aspartic acid, monopotassium salt, mixt. With potassium hydrogen (T-4)-bis(DL-aspartato(2-)-N,O1)magnesate(2-)
(12 Dec 1998)
deficiency, magnesium Can occur due to inadequate intake or impaired intestinal absorption of magnesium. Low magnesium (hypomagnesaemia) is often associated with low calcium (hypocalcaemia) and potassium (hypokalaemia) levels. Deficiency of magnesium causes increased irritability of the nervous system with tetany (spasms of the hands and feet, muscular twitching and cramps, spasm of the larynx, etc.). According to the National Academy of Sciences, the Recommended Dietary Allowances of magnesium are 420milligrams per day for men and 320 milligrams per day for women. The upperlimit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • calcium oxide
    »êÈ­Ä®½·;»ý¼®È¸
  • calcium phosphate
    ÀλêÄ®½·
  • again and again
    ¹Ýº¹Çؼ­
  • and
    ±×¸®°í
  • and not ~ either
    ¶Ç ~ ¾Æ´Ï´Ù(=nor)
  • and so forth
    ±âŸ µîµî
  • and so on
    ..µîµî
  • and such
    µûÀ§,µîµî
  • and that
    ±×°Íµµ,°Ô´Ù°¡
  • both ~ and -
    ~ µµ - µµ (µÑ´Ù)
  • by and by
    ÀÌÀ¹°í
  • by-and-by
    ¹Ì·¡
  • checks and balances
    °ßÁ¦¿Í ±ÕÇü
  • every now and then
    À̵û±Ý
  • here and there
    ¿©±âÀú±â¿¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á